WASHINGTON, D.C. — The Sabin Vaccine Institute joins Global Health Council and organizations across the global health and international development sector to publicly decry the White House's threat to withdraw funds from the World Health Organization.
WASHINGTON, D.C. — In response to the harmful and impulsive decision to withdraw funds from the World Health Organization (WHO), the Sabin Vaccine Institute (Sabin) joins the Center for Health and Gender Equity (CHANGE) and more than 65 other non-governmental organizations and global health institutions in an official letter of solidarity to WHO Director-General Dr. Tedros Adhanom Ghebreyesus and WHO staff worldwide.
WASHINGTON D.C. – Amid the evolving global challenges posed by the novel coronavirus pandemic, immunization professionals must now grapple with deploying routine immunization services in a daunting and ever-shifting landscape. To strengthen immunization professionals’ ability to navigate the complex challenges of their work, Sabin launched the Boost Community (Boost), a global network dedicated to serving immunization professionals, supported by a grant from the Bill & Melinda Gates Foundation.
In our strongest and most unified voice, the Sabin Vaccine Institute condemns racism. Dr. Albert Sabin was a great scientist, and importantly his work led him to fight for equality so that all children everywhere – regardless of race, religion, nationality, gender or socioeconomic status – received his lifesaving polio vaccine.
WASHINGTON, D.C. -- As the COVID-19 vaccine race accelerates, experts recognize that the challenge will not end with the development of a vaccine. The extraordinary effort to make a vaccine available across the globe will only be effective if the majority of people achieve immunity through vaccination.
WASHINGTON, D.C. and ROME, Italy, May 13, 2020 – The Sabin Vaccine Institute (Sabin) and its partner ReiThera Srl today announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services, has exercised the first two options, valued at $20 million, under the 2019 contract to advance the development of vaccines against Ebola Sudan and Marburg viruses through Phase 2 clinical trials.
WASHINGTON, D.C. – The Sabin Vaccine Institute (Sabin) today announced that Professor David Salisbury and Jeffrey P. Libson have been named to the Board of Trustees and Retired Major General Philip K. Russell will transition from Trustee to Special Advisor after more than 25 years of service to the organization.
As those of us who work in immunization know, our actions as individuals may protect us from getting a disease, but it takes vigilance by the entire community to stop the disease from spreading. We have all had to face the reality of this responsibility lately.
WASHINGTON, D.C – The Sabin Vaccine Institute (Sabin) today announced it has received a three-year grant valued at $10.4 million to strengthen vaccine acceptance. In 2019, the World Health Organization identified vaccine hesitancy – the reluctance or refusal to vaccinate despite the availability of vaccines – as one of the top 10 threats to global health.